CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREOF
申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:EP3456711A1
公开(公告)日:2019-03-20
Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof
申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:US10981860B2
公开(公告)日:2021-04-20
Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.